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Abstract
Background: Retinopathy of prematurity (ROP) is a major cause of vision impairment in low birth weight infants. While
previous work has focused on defining the mechanisms of vascular injury leading to retinal neovascularization, recent
studies show that neurons are also affected. This study was undertaken to determine the role of the mitochondrial arginine/
ornithine regulating enzyme arginase 2 (A2) in retinal neuro-glial cell injury in the mouse model of ROP.
Methods and Findings: Studies were performed using wild type (WT) and A2 knockout (A22/2) mice exposed to Oxygen
Induced Retinopathy (OIR). Neuronal injury and apoptosis were assessed using immunohistochemistry, TUNEL (terminal
deoxynucleotidyl transferase dUTP nick end) labeling and Western blotting. Electroretinography (ERG) was used to assess
retinal function. Neuro-glial injury in WT ROP mice was evident by TUNEL labeling, retinal thinning, decreases in number of
rod bipolar cells and glial cell activation as compared with room air controls. Significant reduction in numbers of TUNEL
positive cells, inhibition of retinal thinning, preservation of the rod bipolar cells and prevention of glial activation were
observed in the A22/2 retinas. Retinal function was markedly impaired in the WT OIR mice as shown by decreases in
amplitude of the b-wave of the ERG. This defect was significantly reduced in A22/2 mice. Levels of the pro-apoptotic
proteins p53, cleaved caspase 9, cytochrome C and the mitochondrial protein Bim were markedly increased in WT OIR
retinas compared to controls, whereas the pro-survival mitrochondrial protein BCL-xl was reduced. These alterations were
largely blocked in the A22/2 OIR retina.
Conclusions: Our data implicate A2 in neurodegeneration during ROP. Deletion of A2 significantly improves neuronal
survival and function, possibly through the regulation of mitochondrial membrane permeability mediated apoptosis during
retinal ischemia. These molecular events are associated with decreased activation of glial cells, suggesting a rescue effect on
macroglia as well.
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Introduction
Retinopathy of prematurity (ROP) is a major cause of childhood
vision impairment in developed countries. Despite the improve-
ments in neonatal care, the incidence of ROP does not decline,
probably due to increased survival of premature infants. From the
clinical perspective ROP is considered as a vascular disease and
current treatments target abnormal retinal angiogenesis. However,
despite effective treatment of the vascular injury, many children
suffer vision impairment suggesting a disruption of neuronal
development [1]. It has been shown that the age of onset of ROP
coincides with the time of photoreceptor development [2]. Studies
have reported that rod photoreceptors are affected [3,4,5] and
visual acuity is reduced [6] in ROP patients. Deficits in rod and
rod-bipolar cell sensitivity have been observed several years after
ROP has resolved [5,7]. Recent study has shown that the function
of the post receptor neural retina is significantly impaired in a rat
model of ROP [8,9].
Oxygen induced retinopathy (OIR) in mice is a useful model for
studies aimed at defining the molecular mechanisms of ROP. In
addition to pathological neovascularization, retinal degeneration
[10,11,12] and glial activation [12,13] have been demonstrated.
Apoptosis is reported to be the major mechanism of the retinal
degeneration [11]. Upregulation of the constitutively active
isoform of nitric oxide synthase (NOS), inducible NOS (iNOS)
has been shown to be involved in triggering retinal apoptosis
during OIR by a process involving formation of the highly toxic
oxidant peroxynitrite [11]. Under normal physiological conditions
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supply of L-arginine is limited, NOS will use molecular oxygen to
produce superoxide. Superoxide reacts rapidly with any available
NO to form peroxynitrite. Thus, a deficiency in L-arginine supply
can lead to increased peroxynitrite formation. L-arginine is also
the substrate for the urea/ornithine-producing enzyme, arginase.
Arginase has been shown to limit the normal function of NOS in
aging and disease conditions, including hypertension, ischemia-
reperfusion injury and diabetes [14]. Increases in arginase activity
and arginase 2 mRNA have been reported in the OIR mouse
model [15]. Given the involvement of increased arginase activity
in altering NOS function in other disease conditions and the
demonstrated involvement of iNOS in retinal apoptosis, arginase
could play role in retinal injury associated with OIR.
Arginase exists in two forms, arginase 1 and 2, encoded by
different genes. Arginase 1 (A1) is localized in the cytoplasm and
expressed most abundantly in the liver, while arginase 2 (A2) is a
mitochondrial enzyme, expressed primarily in extrahepatic tissues
[16]. Studies conducted in our laboratory have shown that, in
retina, arginase 1 is expressed in the retinal glia and microglia
[17]. However, the localization of arginase 2 in the retina is not yet
known. The present study is aimed at investigating the role of
arginase 2 in neural cell injury during OIR and its impact on
retinal function.
Results
Deletion of Arginase 2 reduces retinal degeneration
during OIR
In addition to neovascularization, retinal thinning is a major
feature of OIR [11]. In the current study, thickness of the retina
and inner nuclear layer (INL) at P17 (post natal day 17) was
measured using H&E stained sections. As shown in Figure 1,
thickness of retina and INL were significantly reduced in WT OIR
compared to room air (RA) controls (p,0.01), while in A22/2
OIR, thickness of both retinal and INL was significantly preserved
(p,0.01) in comparison with WT OIR. Retinal degeneration was
also studied in double knockout mice lacking one copy of A1 as
well as both copies of A2 (A1+/2 A22/2, deletion of both copies
of A1 is lethal at P10–14). Both retinal and INL thickness were
comparable to that in the A22/2 OIR mice (data not shown).
These results demonstrate that A2 plays an important role in the
neurodegeneration during OIR.
Arginase 2 expression is altered during OIR
A2 is reported to be localized in mitochondria and is known to
be expressed in a variety of tissues including retina [16], but so far
its specific cellular localization in the retina is unknown. In brain
tissue A2 is reported to be localized in neurons and glia [18]. In
the present study, experiments were performed to examine the
expression and localization of A2 in mouse retinal samples using
Western blotting and immunohistochemistry methods. As evident
from Figure 2, increased expression of A2 was observed at P12 in
WT OIR samples compared to WT RA controls. However,
relative levels of A2 protein were slightly reduced in the WT OIR
retina at later stages (Fig. 2A). There was an age dependant
increase in A2 levels in control samples which was not observed in
the OIR retinas. Immunolocoalization analysis of A2 distribution
at P12 in the WT retina showed high levels of expression in
horizontal cells as compared to other retinal cell types (Fig. 2B). A
population of A2 positive cells in the outer margin of the INL was
also strongly immunoreactive for the horizontal cell marker
calbindin (Fig. 2B). Immunostaining of retinal flatmouts using
arginase 2 antibody clearly demonstrated increased expression of
A2 in the horizontal cells of WT OIR retinas (Fig 2C and D).
These results demonstrate that a primary site of A2 distribution is
in horizontal cells and its expression is increased at the start of the
ischemic phase of OIR. Analysis of arginase activity using an assay
for urea formation showed no difference between the WT OIR
and WT RA controls at P12, P14 or P17 (Table 1). This apparent
lack of an effect of the oxygen treatment on arginase activity is
probably due to the fact that the assay measures activity of both
arginase isoforms. A further complicating factor is that arginase 2
immunoreactivity is localized mainly in horizontal cells, which are
relatively few in number compared with other retinal cell types,
whereas arginase 1 is distributed in the Muller glia, which are
abundant in the retina.
OIR-induced apoptosis is reduced in A22/2 retina
Apoptosis is reported to be the major mechanism of retinal
degeneration during OIR [11]. In the present study, retinal
apoptosis was studied in WT RA, WT OIR and A22/2 OIR
mice on P12, P14 and P17. At all stages, the number of TUNEL
(terminal deoxynucleotidyl transferase dUTP nick end labeling)
positive cells was reduced in A22/2 OIR compared to WT OIR
retinas. Further characterization of TUNEL positive cells using
double immunolabeling with neuronal and glial markers con-
firmed that cells undergoing apoptosis in the OIR retina included
amacrine cells (NeuN positive), bipolar cells (PKCa positive),
Muller glia (CRALBP positive) and photoreceptors (recoverin
positive) Numerous TUNEL-positive apoptotic cells were observed
in WT RA sections mainly at P12 and P14, which is due to
developmental apoptosis. The peak of apoptosis during OIR was
observed to be at P14 (Fig. 3A). The number of apoptotic cells was
significantly reduced in A22/2OIR compared to WT OIR at
P14 and P17 (Fig. 3B). This further confirms that deletion of A2
reduces neurodegeneration in the OIR retina.
OIR-induced glial activation is prevented in A22/2 retina
Activation of glial cells is a common feature in the OIR retina
[12,13] and is characterized by increases in the expression of glial
fibrillary acidic protein (GFAP). In normal conditions, GFAP is
expressed by retinal astrocytes whereas following retinal injury,
GFAP is expressed by Muller cells as well. Muller cells are radial
glia whose processes span the retina extending from the nerve fiber
layer to the photoreceptor layer. Figure 4A shows that there was a
slight increase in the levels of GFAP in the WT OIR retina as early
as P12 compared to the WT RA. The enhanced expression of
GFAP in Muller cells was more evident at P14 in WT OIR and
was further increased at P17 as indicated the strong immunore-
activity extending radially from the inner retina through the outer
nuclear layer. However this enhanced level of GFAP expression
was not observed in A22/2 OIR retina at any stage of OIR
studied (Fig. 4A). Quantification of Western blots using Image J
showed that the increase in the expression of GFAP level was
significant in WT OIR at P14 and P17 (p,0.01) compared to WT
RA as well as A22/2 OIR. Similarly, differences in the
expression level of GFAP between WT RA and A22/2 OIR
were not significant, confirming that injury to glial cells was
minimal in A22/2 OIR retina.
OIR-induced loss of rod bipolar cells is reduced in A22/2
retina
Bipolar cells are interneurons that transmit visual signals from
the photoreceptors to the ganglion cells [19]. Function of rod
bipolar cells is reported to be impaired in ROP patients [5,7].
Decreases in numbers of bipolar cells have been reported in the rat
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of A2 deletion on bipolar cell injury during OIR. Immunohisto-
chemistry analysis of retinal sections using an antibody against the
rod bipolar cell marker PKCa confirmed bipolar cell injury in WT
OIR retina (Fig. 5A) as indicated by shorter and /or distorted
axons and smaller cell bodies (Fig. 5B). Quantification of the
number of PKCa positive cells showed that there is a significant
reduction in rod bipolar cell number in WT OIR compared to
WT RA at P17 (Fig. 5C). The number of rod bipolar cells in
A22/2 OIR retina was not significantly different from that in the
WT RA retina. These results demonstrate that rod bipolar cells
are preserved in the A22/2 OIR retina.
Figure 1. Retinal degeneration in WT and A22/2 mice during OIR. A) H & E staining of retinal sections from WT RA, WT OIR and A22/2 OIR
at P17 showing the markedly reduced thickness of retina and INL in WT OIR compared to WT RA, and increased thickness of retina and INL in A22/2
compared to WT OIR at P17. Scale bar 50 mm. B) Representative images used for quantifying the thickness of retina and INL. Scale bar 100 mm. C)
Quantification of retinal and INL thickness. Histogram showing the relative changes in thickness of retina and INL during OIR, quantified using NIH
ImageJ. In comparison with WT RA (100%), thickness of both retina and INL is significantly reduced in WT OIR (P,0.01), while they are significantly
increased in A22/2 OIR compared to WT OIR. (P,0.01), Data presented as mean6SD. N=6. 1 WT RA vs WT OIR, * A22/2 OIR vs WT OIR. GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0022460.g001
Figure 2. Expression of arginase 2 during OIR. A) Western blot analysis showing changes in the expression of A2 during OIR. Increased
expression in WT OIR was observed at P12. B) Immunohistochemistry of retinal cryostat sections at P12 showing A2 (green) expression in horizontal
cells. Calbindin (red) is used as a marker for horizontal cells. Scale bar 100 mm. C) Low magnification confocal images of retinal flat mounts (periphery
is outlined) from WT RA, WT OIR and A2 2/2 OIR at P12 immunostained for A2 showing enhanced levels in the horizontal cells in WT OIR. White
boxes represent area for high magnification images in panel D. Scale bar 100 mm. D) High magnification images of WT RA and WT OIR retinal
flatmounts at P12 immunostained for A2, demonstrating increased A2 expression in the horizontal cells of WT OIR compared with WT RA. Scale bar
50 mm. A minimum of three animals was used for each experiment and representative images are shown. GCL, ganglion cell layer; IPL, inner plexiform
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0022460.g002
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reduced in A22/2 mice
The effect of OIR on retinal function in WT and A22/2 mice
was analyzed using ERG. There have been reports of impaired
retinal function in ROP patients [4,5,21] as well as in rat models of
OIR [2,8,22]. These studies have shown decreases in the
amplitude and sensitivity of the a-wave, suggesting photoreceptor
dysfunction, as well as reductions in b-wave amplitudes, indicating
that retinal interneurons are affected as well. Bipolar cell function
(indicated by the b-wave amplitude) in WT-OIR was shown to be
markedly impaired compared to WT RA (Fig. 6 A, B and C),
while this defect was partially prevented in A22/2 OIR mice.
The b-wave amplitudes in A22/2 OIR mice were significantly
higher than in WT OIR at lower light intensities, as shown in
Figure 6, demonstrating improved retinal function in A22/2
OIR mice. However at higher intensities the responses were
similar in the two OIR groups. These observations are consistent
with our immunolocalization data showing significant preservation
of the rod bipolar cells in the A22/2 OIR mice at P17, compared
to WT OIR mice. Additionally, these data support our
observation that the number of apoptotic cells in the INL of the
A22/2 OIR is significantly reduced as compared with the WT
OIR retinas.
Table 1. Arginase activity in retinal samples.
Age WT RA WT OIR
P12 209.367.6 210.4636.5
P14 264.667.5 232.0622.0
P17 265.0631.2 264.465.6
Arginase activity was analyzed in WT RA and WT OIR retinal samples at P12, P14
and P17 and is shown as nmol/mg protein/min. A minimum of 3 animals were
used in each group and data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0022460.t001
Figure 3. Decreased apoptosis in A22/2 OIR retina. A) TUNEL assay of retinal sections showing the presence of numerous apoptotic cells
(colocalized with DAPI) in WT OIR compared to room air (RA) controls and A22/2 OIR at P14. B) Quantification of TUNEL positive cells showing
significantly increased number in WT OIR at all stages. Numbers of apoptotic cells were significantly reduced in A22/2 OIR compared to WT OIR.
Data presented as mean6SD. C) Characterization of TUNEL positive cells on WT OIR retinal cryostat sections at P14, by double immunolabelling using
NeuN (ganglion and amacrine cells), CRALBP (Muller glia), PKCa (bipolar cells) and recoverin (photoreceptors) antibodies. Insets show magnified
images of TUNEL colocalization with respective cellular markers. N varies from 4–6. 1WT RA vs WT OIR (P,0.01), * A22/2 OIR vs WT OIR (P,0.05).
Scale bar 100 mm. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0022460.g003
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22460Figure 4. Decreased glial activation in A22/2 OIR retina. A) Immunohistochemistry ofretinal cryostat sections from WT RA,WT OIRandA22/2
OIR using anti- GFAP antibody at different stages of hypoxic phase. B) Western blot analysis using retinal homogenates showing the changes in GFAP
expression in WT OIR retina compared to RA and A22/2 OIR during different stages. C) Quantification of GFAP expression levels in WT RA, WT OIR and
A22/2OIRatP12,P14 andP17.Datapresentedasmean6SD.1WTRAvsWT OIR(P,0.01),*A22/2OIRvs WTOIR (P,0.01),Nvariesfrom4–6.Scalebar
100 mm. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0022460.g004
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decreases in p53 and cleaved caspase-9
Studies on potential mechanisms underlying the neuro-glial
protection observed in the A22/2 OIR retina demonstrated the
involvement of p53 mediated signaling mechanisms. The tumor
suppressor and transcription factor p53 (protein 53) is a modulator of
cellular stress responses and activation of p53 can mediate apoptosis
in neurons [23,24,25]. The level of p53 was relatively elevated in WT
OIR retinal homogenates at P12, P14 and P17 compared to WT RA
with maximum increase at P14 (Fig. 7A). Additionally cleaved
caspase 9 was shown to be significantly increased in WT OIR retina
at P14. By contrast with the WT OIR retina, the levels of p53 and
cleaved caspase 9 in the A22/2 OIR retina were always similar to
RA controls. At P14, an increase in levels of the pro-apoptic marker
Bim along with a decrease in survival marker BCLxl was also
observed in WT OIR samples compared to WT RA controls,
consistent with alterations in mitochondrial membrane permeability
leading to cytochrome C release. However these changes were
markedly abrogated in A22/2 OIR retina, demonstrating inhibi-
tion of apoptosis in these samples (Fig. 7B). These studies suggest that
the OIR-induced neuronal injury and the resulting glial activation are
regulated through an apoptotic pathway involving activity of A2, p53
and cleaved caspase 9 via alterations in mitochondrial membrane
permeability.
Discussion
These results identify a novel role of arginase 2 in retinal
neuronal dysfunction associated with ROP. Abnormal vasculature
characterized by vaso-obliteration and pathological angiogenesis is
the most recognized characteristic of ROP. However the vascular
pathology represents only one facet of the disorder. ROP results in
retinal neuronal dysfunction as well [4,5,21,26,27]. However the
cellular mechanisms of the neuronal injury are still unknown. In
the present study we have investigated the impact of A2 deletion
on neurodegeneration, glial activation and retinal function using a
mouse model of OIR.
Retinal degeneration during OIR has been reported previously
[11,12]. Here we demonstrate that deletion of the A2 gene reduces
the neuronal cell loss. Partial deletion of A1 along with A2 did not
confer any additional protection, suggesting that A2 is the more
important isoform of arginase involved in OIR-induced neurode-
generation. Sennlaub et al. [11] have previously shown that
deletion of iNOS significantly reduces retinal thinning during OIR
via reducing neurotoxicity associated with increases in protein
nitration. Further study is required to determine the specific
relationship between activity of arginase 2 and iNOS and
peroxynitrite formation in relation to neuro-glial cell injury.
So far no literature is available on A2 localization in retina.
Studies from our laboratory have shown A1 localization in glial
cells [17]. In the current study we have demonstrated that A2 is
most prominently expressed in horizontal cells and is present at
lower levels in other cells of the inner nuclear layer. Our results are
consistent with studies in brain, where A2 is shown to be present in
neurons [18]. Our Western blot analysis showed that A2 protein
levels were markedly increased immediately after the end of the
hyperoxia exposure on P12 and decreased thereafter. Despite
these alterations in A2 protein levels, total arginase activity
Figure 5. Preservation of bipolar cells in A22/2 OIR retina. A) Immunostaining of WT RA, WT OIR and A22/2OIR retinal sections at P17 using
rod bipolar cell marker PKCa. Scale bar 100 mm B) High magnification images of rod bipolar cells demonstrating the neurodegeneration of rod bipolar
cells in WT OIR retina. Scale bar 25 mm. C) Quantification of PKCa positive cells showing significantly increased number in A22/2OIR retina compared
to WT OIR. Data presented as mean6SD. 1WT RA vs WT OIR (P,0.01), * A22/2 OIR vs WT OIR (P,0.05), N varies from 3–4. GCL, ganglion cell layer;
IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer.
doi:10.1371/journal.pone.0022460.g005
Role of Arginase 2 in Retinal Degeneration
PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22460remained constant. However, the arginase assay measures activity
of both arginase isoforms. Given that the A2 expressing horizontal
cells are relatively few in number compared with the A1 expressing
retinal glial cells, it is likely that activity of arginase 1 masks the
changes in arginase 2 activity.
Even though the horizontal cells are few in number, they are
ideally situated and equipped to influence neuronal function and
survival. As shown in Figure 2, their cell bodies are localized to a
single layer, but are distributed across the entire retina. Their
processes synapse with photoreceptor and bipolar cells and are
also interconnected with other horizontal cells by gap junctions to
form a network across the retina [28]. Moreover, the horizontal
cells express neuronal NOS [29] and are involved in glutamate
signaling [30]. Glutamate is an excitotoxic neurotransmitter and a
Figure 6. Retinal responses. A, B) ERGs recorded from 4 weeks old WT RA, WT OIR, and A22/2 OIR mice at intensities of 7 cd/m
2 (candela per
square meter) and 13 cd/m
2 respectively. The data show averages of responses over both eyes, in 9, 6, and 16 WT RA, WT OIR, and A22/2 OIR mice,
respectively. C) Mean b-wave amplitudes for WT RA, WT OIR, and A22/2 OIR mice are plotted against intensity. Responses are represented as mean
6 SEM of the b-wave amplitudes, measured from the trough of the a-wave to the peak of the b-wave. Asterisks indicate significant differences
between the two WT and A22/2 OIR groups (P,0.05, t-test). WT RA responses were significantly larger compared to both OIR groups at all
intensities studied. Sample size varies from 6–16. * A22/2 OIR vs WT OIR (P,0.05).
doi:10.1371/journal.pone.0022460.g006
Figure 7. Signaling mechanism involved in A2-deficiency mediated neuro-glial protection in OIR retina. A) Western blot analysis
showing the levels of p53, and cleaved caspase 9 in WT RA, WT OIR and A22/2 OIR at stages P12, P14 and P17 of the hypoxic OIR phase. B) Western
blots showing changes in the expression of apoptotic markers Bim, BCLxl and cytochrome C in WT RA, WT OIR and A22/2 OIR at P14. N varies from
3–5, and representative images are shown.
doi:10.1371/journal.pone.0022460.g007
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finding that arginase 2 is expressed mainly in horizontal cells and
that its deletion reduces loss of retinal neurons expressing markers
for photoreceptor, bipolar and amacrine cells, we speculate that
neuronal cell injury during oxygen-induced retinopathy involves
arginase 2-induced increases in glutamate formation and dysreg-
ulation of neuronal NOS function. Further studies are needed to
investigate these possibilities.
Based on our observation that apoptosis was maximal at P14,
we hypothesize that oxygen-induced obliteration of the immature
retinal vessels leads to relative retinal hypoxia/ischemia which
increases expression/activity of A2 leading to death of retinal
neurons. Similar to Sennlaub et al [11], we observed that the
apoptosis peaked at P14 and the majority of the apoptotic cells
were in the INL. The decrease in A2 at P14 and later is likely due
to degeneration of A2 expressing cells. Lachapelle et al [27] have
reported significant loss of horizontal cells in neonatal rats exposed
to hyperoxia. It is also possible that the activity per amount of
enzyme is higher irrespective of expression level and hence
arginase activity could be present at the later stages of OIR even
though total protein levels are reduced. This could lead to
alterations in arginine metabolism resulting in a decrease in nitric
oxide formation and/or increases in polyamines and/or gluta-
mate. Polyamines have been implicated in exitotoxic neuronal
death in retina [32] and the neurotoxic actions of glutamate are
well established [33].
In addition to neovascularization and retinal thinning, activa-
tion of glial cells is another hallmark of ROP [12,13]. This has
been confirmed in our study. Absence of Muller glial activation in
A22/2 OIR suggests an adverse effect of A2 on glia as well. Our
data also demonstrate that glial activation follows neuronal
apoptosis. While the peak of apoptosis was at P14, glial injury
was greatest at P17. It is possible that the soluble factors released
by cells undergoing death and/or cellular debris resulting from
increased apoptosis are causing glial cell injury. According to
Fletcher et al. [1], neurochemical changes observed during OIR
could be attributed to changes in Muller cells. Our data further
demonstrate that significantly reduced apoptosis in A22/2 OIR
retinas is associated with decreases in glial cell activation. Downie
et al. [12] have shown that up regulation of GFAP is restricted
mainly to avascular and mid peripheral retina suggesting an
involvement of relative retinal hypoxia secondary to the vascular
injury. However, more detailed studies are required to examine
whether neurodegeneration and/or vascular pathology underlie
the macroglial activation observed in OIR.
The neuroprotective effect of A2 deletion was further confirmed
by the ERG analysis showing improved retinal function in A22/
2 OIR mice. Defects in retinal function as shown by ERG have
been reported for rat OIR models [8,9,22]. However, our data are
the first we are aware of showing functional losses in the mouse
OIR model. Our finding of decreases in bipolar cell number
during OIR is consistent with our observation of decreases in the
b-wave amplitude of the ERG at low light intensity. Clinical
studies have shown loss of neuronal function in ROP patients
[3,4,6]. Deficits in rod and rod-bipolar cell sensitivity are still
evident several years after ROP has resolved [5,7]. The current
treatment for ROP is laser photocoagulation or cryotherapy to
destroy the ischemic tissue and reduce metabolic demand which
promotes regression of the pathological blood vessels. Yet, many
patients suffer from vision problems later suggesting loss of
neuronal function. Since the development of laser surgery there
has been little progress in the treatment of ROP. Based on
increasing evidence that neurons as well as vascular endothelial
cells are affected in ischemic retinopathies, it is suggested that
retinal neurons are important targets in developing novel therapies
for ischemic retinopathies.
It has been shown that NOS signaling is involved in retinal
apoptosis during retinal ischemia related disorders [11,34]. Several
laboratories have reported that NO neurotoxicity is responsible at
least in part for neural degeneration following retinal ischemia
[34,35]. Our current data show that deletion of the arginase 2
gene significantly reduces neurodegeneration associated with OIR.
This beneficial effect could be through the regulation of NO
signaling due to increase availability of the NOS substrate L-
arginine. Another possibility is through an increase in polyamine
metabolism since excessive arginase activity can increase the
formation of polyamines via activation of the ornithine/polyamine
pathway. It has been shown that excessive polyamine formation is
involved in exitotoxic neuronal death in retina [32]. Further,
polyamine metabolites have been shown to be involved in the
pathogenesis of ischemic brain damage [36,37,38]. However, in
the current study we have not investigated whether the regulation
of NOS signaling or polyamine pathway is responsible for the
neuroprotection in A2 deficient mice during OIR. Instead, our
focus was on the apoptotic signaling involved in this process.
Apoptosis can occur either through alterations in mitochondrial
membrane permeability, release of cytochrome C and subsequent
activation of caspases (intrinsic pathway) or via death receptor
pathway (extrinsic pathway) involving FAS ligand or TNF [39].
Our data show that the major mechanism of apoptosis during
OIR is through alterations in mitochondrial membrane perme-
ability mediated by p53. Considering the predominant localization
of A2 in mitochondria, our data showing reduced levels of Bim,
cytochrome C and cleaved caspase 9 in A22/2 compared to WT
during OIR suggest that neuronal apoptosis during ROP involves
the intrinsic pathway. Further, targeting arginase 2 activity may
provide a new therapeutic strategy for the prevention of neuro-
glial injury in ROP patients.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the Georgia Health Sciences University. All surgery
was performed under avertin (2, 2, 2 tribromoethanol, Sigma)
anesthesia, and all efforts were made to minimize suffering.
Antibodies
Antibodies were purchased from Santacruz (Arginase 2,
Cellular Retinaldehyde-Binding Protein (CRALBP)), Sigma (Cal-
bindin, Glial Fibillary Acidic Protein/GFAP, Tubulin), Abcam
(Protein Kinase Ca/PKCa), Millipore (Recoverin) and Cell
Signaling (P53, Cleaved Caspase 9, Cytochrome C, BCLxl and
Bim).
Animal model of OIR
WT controls (C57BL6) and mice deficient in arginase 2 (A22/
2) on C57BL6 background maintained in our animal facility were
used for this study. A2
2/2 mice developed by Shi et al [40] were
provided by Dr. Cederbaum (University of California, Los
Angeles, California) with the permission of Dr. O’Brien.
Homozygous arginase 2-deficient animals are fertile and do not
have a distinguishable phenotype. The mouse model for OIR was
generated according to the method of Smith et al [41] with minor
modifications. Briefly, on P7 newborn mice are placed with their
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room air on P12. The hyperoxia treatment causes vaso-
obliteration, but retinal development persists which results in
relative retinal hypoxia when the mice are returned to room air.
During the relative hypoxic period, the animals develop extensive
retinal neovascularization and undergo glial cell activation and
neuronal apoptosis. Mice were sacrificed at various times after the
hyperoxia treatment and their retinae were collected and analyzed
as described below.
Morphometric analysis
Retinal morphology was studied on retinal cryostat sections
from WT room air (WT RA), WT OIR and A22/2 OIR mice
on P17. Sagital sections (10 um) containing the optic nerve were
collected 20 um apart from one another, and stained with
hematoxylin and eosin (H&E, Fischer Scientific). Digitalized
images were taken 1000 mm from the optic nerve and four
sections per animal were used. Thickness of the retina and inner
nuclear layer (INL) was measured using NIH ImageJ.
TUNEL assay
Apoptotic cells were studied using TUNEL (Terminal deox-
ynucleotidyl transferase dUTP nick end labeling) assay on
cryosections (Fluorescein Insitu Cell death detection kit, Millipore)
as per the manufacture’s protocol. Quantification of TUNEL
positive cells on retinal cryosection images was performed
manually from optic disc to periphery. A minimum of four
sections (20 um apart to one another) per animal were used.
Immunohistochemistry
Eyes were enucleated, fixed in 4% paraformaldehyde (over-
night, 4uC), washed in PBS and retinas were isolated and
cryoprotected in 30% sucrose. Cryostat sections (10 um) were
permeabilized in 1% Triton (20 min) and blocked in 10% normal
goat serum containing 10% BSA (1 h). Sections were then
incubated overnight in respective primary antibodies (4uC). On
day two, they were incubated (1 h) in Flourescein or Texas red
conjugated secondary antibodies (Molecular Probes), washed in
PBS and mounted with Vectashield (Vector Laboratories).
Retinal flatmount staining
Immunostaining on retinal flatmounts was performed as
described previously [42] with minor modifications. Eyes were
enucleated, fixed in 4% paraformaldehyde (overnight, 4uC),
retinas were isolated washed in PBS and cut towards the optic
disc to get a flower shape. The tissue was then permeabilized in
10% Triton X-100 for 20 min, blocked in 10% NGS/1% BSA/
0.1% Triton X-100 and incubated in primary antibody overnight
(4uC). The retinas were incubated in respective secondary
antibodies for 4 h at 4uC, washed in PBS and mounted using
Vectashield.
Arginase activity
Arginase activity was measured using a colorimetric determi-
nation of urea production from L-arginine as described previously
[43]. In brief, retinas were placed in Tris/EDTA buffer containing
protease and phosphatase inhibitors and exposed to 3 freeze-thaw
cycles and centrifuged at 14,000xg for 15 min at 4uC. Lysate
(25 ml) was heated with MnCl2 (10
23 M) for 10 minutes at 56uCt o
activate arginase. The mixture was then incubated with 50 mL
L-arginine (0.5 M, pH 9.7, 1 h, 37uC) to hydrolyze the L-arginine.
The hydrolysis reaction was stopped with acid and the mixture
was then heated at 100uC with 25 mL a-Isonitrosopropiophenone
(9% a-ISPF in EtOH) for 45 minutes for the colorimetric reaction.
The samples were kept in dark at room temperature for 10
minutes and absorbance was measured at 540 nm.
Western blotting
Retinal homogenates were prepared using RIPA buffer
(Millipore) containing protease and phosphatase inhibitors (com-
plete mini and phosSTOP, respectively (Roche Applied Sciences).
Proteins were separated on SDS-PAGE and transferred onto
nitrocellulose membrane (Millipore), blocked in 5% milk or 3%
BSA in TBST (Tris buffered saline with 0.5% Tween-20). The
membrane was incubated overnight (4uC) in primary antibodies
diluted in the blocking solution, washed and incubated in
respective secondary antibodies (HRP conjugated, GE Healthcare)
for 1 h at room temperature and developed using Enhanced
Chemiluminescence (ECL,GE Health Care) or Westdura Detec-
tion (Pierce).
Bipolar cell quantification
Cryostat sections from WT RA, WT OIR and A22/2OIR at
P17 were immunostained using protein kinase C alpha (PKCa,
marker for rod bipolar cells) antibody as described above. Images
from six sections (20 um apart) were taken 1000 mm from optic
nerve and the number of bipolar cell bodies was quantified
manually across a length of 750 mm.
Electroretinogram
Mice were dark-adapted for 12 hours, anesthetized with
Ketamine/Xylazine (80/16 mg/kg i.p.), and eyes were anesthe-
tized and dilated (with Proparacaine, Tropicamide, and Phenyl-
ephrine). Signals were recorded via DTL electrodes on each eye,
referenced to needle electrodes in the cheeks. Visual stimuli were
generated by 5 ms duration flashes of a white LED. Responses
were averaged across the two eyes for each mouse.
Microscopy
Imaging of retinal cryostat sections was performed using a Zeiss
Axioplan Imager Microscope and images taken using a Zeiss
Axiocam digital camera, and Zeiss Axiovision 4.8.2 software.
Retinal flatmounts were images using confocal microscope (Zeiss
LSM 510 META).
Statistical analysis
One-way ANOVA with posthoc test using GraphPad Prism
software was performed in all analyses unless otherwise stated.
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